Cargando…

Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options

Anhedonia is a condition in which the capacity of experiencing pleasure is totally or partially lost, and it refers to both a state symptom in various psychiatric disorders and a personality trait. It has a putative neural substrate, originating in the dopaminergic mesolimbic and mesocortical reward...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatzigiakoumis, Daniele Stavros, Martinotti, Giovanni, Giannantonio, Massimo Di, Janiri, Luigi
Formato: Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089992/
https://www.ncbi.nlm.nih.gov/pubmed/21556280
http://dx.doi.org/10.3389/fpsyt.2011.00010
_version_ 1782203102058774528
author Hatzigiakoumis, Daniele Stavros
Martinotti, Giovanni
Giannantonio, Massimo Di
Janiri, Luigi
author_facet Hatzigiakoumis, Daniele Stavros
Martinotti, Giovanni
Giannantonio, Massimo Di
Janiri, Luigi
author_sort Hatzigiakoumis, Daniele Stavros
collection PubMed
description Anhedonia is a condition in which the capacity of experiencing pleasure is totally or partially lost, and it refers to both a state symptom in various psychiatric disorders and a personality trait. It has a putative neural substrate, originating in the dopaminergic mesolimbic and mesocortical reward circuit. Anhedonia frequently occurs in mood disorders, as a negative symptom in schizophrenia, and in substance use disorders. In particular, we focus our attention on the relationships occurring between anhedonia and substance use disorders, as highlighted by many studies. Several authors suggested that anhedonia is an important factor involved in relapse as well as in the transition from recreational use to excessive drug intake. In particular, anhedonia has been found to be a frequent feature in alcoholics and addicted patients during acute and chronic withdrawal as well as in cocaine, stimulant, and cannabis abusers. Furthermore, in subjects with a substance dependence disorder, there is a significant correlation between anhedonia, craving, intensity of withdrawal symptoms, and psychosocial and personality characteristics. Therefore treating anhedonia in detoxified alcohol-dependent subjects could be critical in terms of relapse prevention strategies, given its strong relationship with craving.
format Text
id pubmed-3089992
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-30899922011-05-09 Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options Hatzigiakoumis, Daniele Stavros Martinotti, Giovanni Giannantonio, Massimo Di Janiri, Luigi Front Psychiatry Psychiatry Anhedonia is a condition in which the capacity of experiencing pleasure is totally or partially lost, and it refers to both a state symptom in various psychiatric disorders and a personality trait. It has a putative neural substrate, originating in the dopaminergic mesolimbic and mesocortical reward circuit. Anhedonia frequently occurs in mood disorders, as a negative symptom in schizophrenia, and in substance use disorders. In particular, we focus our attention on the relationships occurring between anhedonia and substance use disorders, as highlighted by many studies. Several authors suggested that anhedonia is an important factor involved in relapse as well as in the transition from recreational use to excessive drug intake. In particular, anhedonia has been found to be a frequent feature in alcoholics and addicted patients during acute and chronic withdrawal as well as in cocaine, stimulant, and cannabis abusers. Furthermore, in subjects with a substance dependence disorder, there is a significant correlation between anhedonia, craving, intensity of withdrawal symptoms, and psychosocial and personality characteristics. Therefore treating anhedonia in detoxified alcohol-dependent subjects could be critical in terms of relapse prevention strategies, given its strong relationship with craving. Frontiers Research Foundation 2011-03-17 /pmc/articles/PMC3089992/ /pubmed/21556280 http://dx.doi.org/10.3389/fpsyt.2011.00010 Text en Copyright © 2011 Hatzigiakoumis, Martinotti, Di Giannantonio and Janiri. http://www.frontiersin.org/licenseagreement This is an open-access article subject to an exclusive license agreement between the authors and Frontiers Media SA, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
spellingShingle Psychiatry
Hatzigiakoumis, Daniele Stavros
Martinotti, Giovanni
Giannantonio, Massimo Di
Janiri, Luigi
Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
title Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
title_full Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
title_fullStr Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
title_full_unstemmed Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
title_short Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
title_sort anhedonia and substance dependence: clinical correlates and treatment options
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089992/
https://www.ncbi.nlm.nih.gov/pubmed/21556280
http://dx.doi.org/10.3389/fpsyt.2011.00010
work_keys_str_mv AT hatzigiakoumisdanielestavros anhedoniaandsubstancedependenceclinicalcorrelatesandtreatmentoptions
AT martinottigiovanni anhedoniaandsubstancedependenceclinicalcorrelatesandtreatmentoptions
AT giannantoniomassimodi anhedoniaandsubstancedependenceclinicalcorrelatesandtreatmentoptions
AT janiriluigi anhedoniaandsubstancedependenceclinicalcorrelatesandtreatmentoptions